Combined Therapeutics
Business Services · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
13 Rue Raymond Losserand, Paris, Ile-de-...Phone Number
(617) 409-5260Website
www.combinedtx.comRevenue
<$5 MillionIndustry
About Combined Therapeutics
Combined Therapeutics Org Chart
Is Combined Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Combined Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Combined Therapeutics is spiking on competitors!
Earning: See what the market has to say on Combined Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Combined Therapeutics has new funding data
Check if Combined Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Combined Therapeutics
Product Launch: Get notified when Combined Therapeutics launches new products
Click to see if Combined Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Combined Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Combined Therapeutics
Compare insights from companies similar to Combined Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Combined Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Combined Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Combined Therapeutics.
Combined Therapeutics Tech Stack
A closer look at the technologies used by Combined Therapeutics
Most Recent Scoops
Combined Therapeutics News & Media
Combined Therapeutics CEO, Romain Micol, to Present at the World Vaccine Congress Europe 2023
Dr. Romain Micol, President and Chief Executive Officer, to present advancements with the MOPCTx mRNA platform Promising preclinical results in mice and non-human primates validate MOPCTx Platform's potential BOSTON, Oct. 11, 2023 /PRNewswire/ -- Combined Therapeutics Inc. (CTx), a...Combined Therapeutics to Present Multi-Organ Protection (MOP) mRNA Vaccine Platform at the 3rd mRNA-Based Therapeutics Summit
BOSTON, July 25, 2023 /PRNewswire/ -- Combined Therapeutics, Inc. (CTx), a privately held biotechnology company developing the next generation of mRNA therapeutics with a novel modified-mRNA platform to treat and prevent infectious diseases and cancer, today announced the participation of...Combined Therapeutics to Present its Next-Generation mRNA-Based Vaccine Platform at the World Vaccine Congress 2023
BOSTON, March 30, 2023 /PRNewswire/ -- Combined Therapeutics Inc. (CTx), a privately held biotechnology company developing the next generation of mRNA therapeutics with a novel modified-mRNA platform to treat and prevent infectious diseases and cancer, today announced its participation in...Combined Therapeutics Granted Patent for its mRNA Vaccine Platform by USPTO
BOSTON, March 13, 2023 /PRNewswire/ -- Combined Therapeutics Inc. (CTx), a privately held biotechnology company developing the next generation of mRNA therapeutics with a novel modified-mRNA platform to prevent infectious diseases and treat cancer, today announced its intellectual...
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Combined Therapeutics
Combined Therapeutics is a privately held biotechnology company focused on developing advanced mRNA vaccines and therapeutics aimed at preventing infectious diseases and treating cancer. Their proprietary mRNA platform enhances safety and efficacy by targeting therapeutic protein expression in specific tissues while minimizing off-target effects. T... Read More